---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-21-001484"
form_type: "8-K"
ticker: "IGC"
cik: "0001326205"
company_name: "IGC Pharma, Inc."
filed_at: "2021-10-15T23:59:59+00:00"
generated_at: "2026-06-28T20:29:28.478341+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# IGC shareholders approve director election, ratify auditor, and authorize 3.5M share equity grant

## Summary
- Richard Prins elected as Class B director, term through 2024 annual meeting.
- Manohar Chowdhry & Associates ratified as independent auditor for fiscal 2022.
- Board authorized grant of up to 3,500,000 common shares to employees, advisors, directors, and consultants.
- Meeting turnout: 37,257,143 shares voted (≈73% of outstanding); 21,876,265 broker non-votes.
- All four proposals passed; adjournment proposal was unnecessary.

## SEC filing metadata
- accession: 0001185185-21-001484
- form_type: 8-K
- ticker: IGC
- cik: 0001326205
- company_name: IGC Pharma, Inc.
- filed_at: 2021-10-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326205/000118518521001484/0001185185-21-001484-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326205/000118518521001484/indiaglob20211015_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-21-001484
- JSON: https://secwatch.observer/filing/0001185185-21-001484.json
- Plain text: https://secwatch.observer/filing/0001185185-21-001484.txt

## Key facts
- Executive change
  Richard Prins was elected as Class B director at IGC Pharma, Inc..
  - Action: elected
  - Role: Class B director
  source text: On October 15, 2021, Richard Prins was elected to India Globalization Capital’s (the “Company”) Board of Directors at the Annual Meeting, to serve as a Class B director
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326205/000118518521001484/0001185185-21-001484-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.